Quabodepistat

N/A

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NameQuabodepistat
Drug Alias NameOPC-167832
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors
TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPhilippinesSouth Africa +[9
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A